Melanoma to Vitiligo: The Melanocyte in Biology & Medicine-Joint Montagna Symposium on the Biology of Skin/PanAmerican Society for Pigment Cell Research Annual Meeting

Affiliations

• ¹ Department of Dermatology, Oregon Health & Science University, Portland, Oregon; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
• ² Research and Development Service, VA Maryland Health Care System, Baltimore, Maryland; Departments of Dermatology and Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland.
• ³ HudsonAlpha Institute for Biotechnology, Huntsville, Alabama; Department of Genetics, Stanford University, Stanford, California.
• ⁴ Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California; Department of Dermatology, University of California, San Francisco, San Francisco, California.
• ⁵ Departments of Therapeutic Radiology and Dermatology and Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut.
• ⁶ Department of Dermatology, University of California, San Francisco, San Francisco, California.
• ⁷ School of Molecular Biosciences and College of Arts and Sciences, Washington State University Vancouver, Vancouver, Washington.
• ⁸ The Markey Cancer Center and the Departments of Toxicology and Cancer Biology and Pediatrics, University of Kentucky College of Medicine, Lexington, Kentucky.
• ⁹ Departments of Dermatology and Immunology & Microbiology, University of Colorado School of Medicine, Aurora, Colorado; Denver VA Medical Center, Denver, Colorado.
• ¹⁰ Huntsman Cancer Institute and Departments of Oncological Sciences and Surgery, University of Utah Health Sciences Center, Salt Lake City, Utah.
• ¹¹ Department of Dermatology, Oregon Health & Science University, Portland, Oregon; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon; Department of Pharmaceutical Sciences, College of Pharmacy, Linus Pauling Institute, and Molecular and Cellular Biology Program, Oregon State University, Corvallis, Oregon.
• ¹² Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
• ¹³ Oncology Research Institute, Loyola University Chicago, Maywood, Illinois; Departments of Dermatology and Microbiology and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
• ¹⁴ Division of Dermatology, Department of Medicine, and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, California.
• ¹⁵ Department of Dermatology, Oregon Health & Science University, Portland, Oregon; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon; Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, Oregon.
• ¹⁶ Ronald O. Perelman Department of Dermatology and Department of Cell Biology, New York University School of Medicine, New York, New York.
• ¹⁷ Genetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.
• ¹⁸ Department of Dermatology, University of Wisconsin-Madison, Madison, Wisconsin.
• ¹⁹ Department of Dermatology, Oregon Health & Science University, Portland, Oregon.
• ²⁰ Department of Dermatology, Oregon Health & Science University, Portland, Oregon; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon. Electronic address: kuleszma@ohsu.edu.